Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Back to Erythema Multiforme Major

Erythema Multiforme Major — NIH Grants & Funding

Active and recent NIH-funded research on Erythema Multiforme Major. Data from NIH RePORTER, last 36 months.

MONDO:0044719

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Erythema Multiforme Major has emerging NIH research funding with 1 grant totaling $800K.

1funded grants from NIH

Portfolio: $800KCumulative: $800K0 active1 completed1 PIs1 institutions

By Research Theme

Epi / Nat. History

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Erythema Multiforme Major. Strongest funded area: Epidemiology / Natural History.

Clinical ResearchTrials Active, No NIH Grants

1 clinical trial registered but no NIH-funded clinical or translational research grants found for erythema multiforme major. Trials may be industry-sponsored or funded through non-NIH sources.

Adjacent Research(9 grants)

These grants mention Erythema Multiforme Major as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(9)

OtherUG3Active

Harnessing translational research to advance understanding and clinical care in antibiotic allergy

Divito, Sherrie·BRIGHAM AND WOMEN'S HOSPITAL·BOSTON, MA

$443,527 (FY2025)

NIH RePORTER

OtherR13Completed

SCAR 2025: Stronger Together

Phillips, Elizabeth·VANDERBILT UNIVERSITY MEDICAL CENTER·NASHVILLE, TN

$60,000 (FY2025)

NIH RePORTER

OtherR01Completed

Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions

Zhou, Li·BRIGHAM AND WOMEN'S HOSPITAL·BOSTON, MA

$702,476 (FY2022)

NIH RePORTER

OtherR01Completed

Construction of Conjunctival Equivalents Using Molecular Deposition Techniques

Dartt, Darlene·SCHEPENS EYE RESEARCH INSTITUTE·BOSTON, MA

$394,000 (FY2023)

NIH RePORTER

OtherR01Completed

Systematic Discovery of Bioactivation-Associated Structural Alerts

MILLER, GROVER et al.·WASHINGTON UNIVERSITY·SAINT LOUIS, MO

$374,783 (FY2022)

NIH RePORTER

OtherR01Completed

Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)

Meintjes, Graeme et al.·UNIVERSITY OF CAPE TOWN·RONDEBOSCH

$308,214 (FY2025)

NIH RePORTER

OtherR21Completed

Synthetic osteo-odonto-keratoprosthesis (OOKP, Tooth-in-Eye surgery)

Tayebi, Lobat·MARQUETTE UNIVERSITY·MILWAUKEE, WI

$208,977 (FY2024)

NIH RePORTER

OtherK43Completed

IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)

Peter, Jonathan·UNIVERSITY OF CAPE TOWN LUNG INSTITUTE·CAPE TOWN

$113,400 (FY2022)

NIH RePORTER

OtherR13Completed

Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) 2023

Phillips, Elizabeth·VANDERBILT UNIVERSITY MEDICAL CENTER·NASHVILLE, TN

$45,133 (FY2023)

NIH RePORTER

NIH Grants & Funding for Erythema Multiforme Major | Kisho | Kisho

Kisho

Erythema Multiforme Major — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding Gap Analysis

Adjacent Research(9 grants)

Other(9)

Harnessing translational research to advance understanding and clinical care in antibiotic allergy

SCAR 2025: Stronger Together

Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions

Construction of Conjunctival Equivalents Using Molecular Deposition Techniques

Systematic Discovery of Bioactivation-Associated Structural Alerts

Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)

Synthetic osteo-odonto-keratoprosthesis (OOKP, Tooth-in-Eye surgery)

IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)

Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) 2023

Top Funded Institutions

Top Principal Investigators